Home › Esophageal Adenocarcinoma
Pag-aaral pangklinika para sa Esophageal Adenocarcinoma na nagre-recruit sa U.S.
47 pag-aaral para sa Esophageal Adenocarcinoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY18 pag-aaral
- Boston, MA13 pag-aaral
- Houston, TX12 pag-aaral
- Nashville, TN11 pag-aaral
- Arlington, VA11 pag-aaral
- Durham, NC10 pag-aaral
- Jacksonville, FL9 pag-aaral
- Baldwin Park, CA9 pag-aaral
- St. Louis, MO9 pag-aaral
- Queens, NY9 pag-aaral
- Los Angeles, CA9 pag-aaral
- Rochester, MN9 pag-aaral
- Dallas, TX8 pag-aaral
- Seattle, WA8 pag-aaral
- Pittsburgh, PA8 pag-aaral
- Philadelphia, PA8 pag-aaral
- Chicago, IL8 pag-aaral
- Orange, CA7 pag-aaral
- Ann Arbor, MI7 pag-aaral
- Aurora, CO6 pag-aaral
- Minneapolis, MN6 pag-aaral
- Washington, DC6 pag-aaral
- Portland, OR6 pag-aaral
- Cleveland, OH6 pag-aaral
- Indianapolis, IN6 pag-aaral
- Evanston, IL6 pag-aaral
- San Antonio, TX5 pag-aaral
- Denver, CO5 pag-aaral
- Charleston, SC5 pag-aaral
- New Haven, CT5 pag-aaral
- Greenburgh, NY5 pag-aaral
- Rochester, NY5 pag-aaral
- Kansas City, MO5 pag-aaral
- Sioux Falls, SD5 pag-aaral
- Newport Beach, CA4 pag-aaral
- Scottsdale, AZ4 pag-aaral
- Atlanta, GA4 pag-aaral
- Las Vegas, NV4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Oklahoma City, OK4 pag-aaral
Ayos sa estado
- Alaska3 pag-aaral
- Arizona10 pag-aaral
- Arkansas4 pag-aaral
- California22 pag-aaral
- Colorado11 pag-aaral
- Connecticut7 pag-aaral
- Delaware3 pag-aaral
- District of Columbia4 pag-aaral
- Florida15 pag-aaral
- Georgia5 pag-aaral
- Illinois11 pag-aaral
- Indiana6 pag-aaral
- Iowa5 pag-aaral
- Kansas5 pag-aaral
- Louisiana3 pag-aaral
- Maryland6 pag-aaral
- Massachusetts13 pag-aaral
- Michigan9 pag-aaral
- Minnesota14 pag-aaral
- Missouri11 pag-aaral
- Nebraska4 pag-aaral
- Nevada5 pag-aaral
- New Jersey9 pag-aaral
- New York20 pag-aaral
- North Carolina12 pag-aaral
- Ohio12 pag-aaral
- Oklahoma4 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania15 pag-aaral
- South Carolina6 pag-aaral
- South Dakota5 pag-aaral
- Tennessee13 pag-aaral
- Texas19 pag-aaral
- Utah5 pag-aaral
- Virginia13 pag-aaral
- Washington9 pag-aaral
- Wisconsin7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07221149Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06324357Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06203600Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07603375Lucid Registry Study
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05965999Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06005493Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07546812Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06687603A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07818018Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Nagre-recruit
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05753748A Study of KK2269 in Adult Participants With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06266299Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07431281Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07282912A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07090499mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT05677490A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07544589A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07222657Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT04221893Obeticholic Acid for Prevention in Barrett's Esophagus
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT04939051A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06657144Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.